Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma
Authors
Keywords
Curcumin, E1A binding protein P300, Anti-programmed cell death-1, Transforming growth factor beta 1, Immune evasion, Hepatocellular carcinoma
Journal
LIFE SCIENCES
Volume -, Issue -, Pages 119359
Publisher
Elsevier BV
Online
2021-03-20
DOI
10.1016/j.lfs.2021.119359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma
- (2020) Haijing Deng et al. Liver Cancer
- Midbrain control of breathing and blood pressure: The role of periaqueductal gray matter and mesencephalic collicular neuronal microcircuit oscillators
- (2020) Michael George Zaki Ghali EUROPEAN JOURNAL OF NEUROSCIENCE
- The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells
- (2020) Dong Young Kang et al. Cancers
- Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
- (2020) Hidetaka Yasuoka et al. Scientific Reports
- Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3
- (2020) Taeko Hayakawa et al. CANCER SCIENCE
- Down-regulation of Gremlin1 inhibits inflammatory response and vascular permeability in chronic idiopathic urticaria through suppression of TGF-β signaling pathway
- (2020) Shengming Qu et al. GENE
- Synergistic anti-liver cancer effects of curcumin and total ginsenosides
- (2020) Zhe Deng et al. World Journal of Gastrointestinal Oncology
- Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma
- (2020) Qiu-Ju Sheng et al. World Journal of Gastrointestinal Oncology
- Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma
- (2019) Decai Tang et al. INTEGRATIVE CANCER THERAPIES
- p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells
- (2019) Yuanguo Wang et al. HEPATOLOGY
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
- (2019) Alexander Thiem et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HucMSCs-Derived miR-206-Knockdown Exosomes Contribute to Neuroprotection in Subarachnoid Hemorrhage Induced Early Brain Injury by Targeting BDNF
- (2019) Hao Zhao et al. NEUROSCIENCE
- Immunotherapy for hepatocellular carcinoma
- (2019) Yin Zongyi et al. CANCER LETTERS
- Mammalian target of rapamycin and p70S6K mediate thrombin-induced nuclear factor-κB activation and IL-8/CXCL8 release in human lung epithelial cells
- (2019) Chien-Huang Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma
- (2018) Feng Liao et al. ARCHIVES OF ORAL BIOLOGY
- Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers
- (2018) Kaustubh A. Gawde et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer
- (2018) Milad Hashemzehi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma
- (2018) Shi-Lu Chen et al. CANCER RESEARCH
- Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
- (2018) T. Mocan et al. Clinical & Translational Oncology
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
- (2018) Stéphanie Liénart et al. SCIENCE
- Thrombin Induces CCL2 Expression in Human Lung Fibroblasts via p300 Mediated Histone Acetylation and NF-KappaB Activation
- (2017) Xiaoling Deng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
- (2017) Kelsy C Cotto et al. NUCLEIC ACIDS RESEARCH
- Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation
- (2017) Zhi-Qiang Wei et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Thrombin Activates Latent TGFβ1 via Integrin αvβ1 in Gingival Fibroblasts
- (2016) W.H. Yang et al. JOURNAL OF DENTAL RESEARCH
- Anticoagulant activities of curcumin and its derivative
- (2012) Dong-Chan Kim et al. BMB Reports
- Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma
- (2010) Yu-Hua Xue et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search